Brought to you by

Lexicon Genetics completes $205mm IPO
18 Apr 2000
Executive Summary
Lexicon Genetics has completed a 10mm share IPO, priced at $22 each, resulting in net proceeds of about $205mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com